Related Experiment Video

Updated: Jun 5, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor

Pedro Cuevas1, Fernando Carceller, Javier Angulo

  • 1Servicio de Histología, IRYCIS, E-28034 Madrid, Spain. pedro.cuevas@hrc.es

Neuroscience Letters
|January 4, 2011
PubMed

Insights

A novel fibroblast growth factor (FGF) inhibitor, 2,5-dihydroxyphenyl-sulfonate (2,5DHPS), shows promise for treating malignant glioma. This agent stimulates tumor cell death, reduces invasion, and inhibits angiogenesis, improving chemotherapy efficacy.

Area of Science:

  • Oncology
  • Neuro-oncology
  • Pharmacology

Background:

  • Glioblastoma prognosis remains poor despite multimodal therapies.
  • Tumor angiogenesis and invasion are key factors in glioblastoma's poor outcome.
  • Current anti-angiogenic therapies offer limited, palliative benefits.

Purpose of the Study:

  • To investigate the potential of fibroblast growth factor (FGF) inhibition as a therapeutic strategy for glioblastoma.
  • To evaluate the efficacy of 2,5-dihydroxyphenyl-sulfonate (2,5DHPS), an FGF inhibitor, in preclinical glioblastoma models.

Main Methods:

  • Assessment of 2,5DHPS effects on glioblastoma cell apoptosis and invasion.
  • Evaluation of 2,5DHPS's impact on tumor-associated angiogenesis.
  • Testing 2,5DHPS in combination with chemotherapy in an orthotopic rat brain tumor model.

Main Results:

  • 2,5DHPS stimulated glioblastoma cell apoptosis.
  • 2,5DHPS inhibited glioblastoma cell invasion and suppressed tumor angiogenesis.
  • Combined 2,5DHPS and chemotherapy treatment augmented therapeutic efficacy in vivo.

Conclusions:

  • FGF inhibition via 2,5DHPS presents a promising therapeutic avenue for malignant glioma.
  • 2,5DHPS demonstrates multifaceted anti-tumor activity, including direct cytotoxicity and anti-angiogenic effects.
  • 2,5DHPS enhances chemotherapy effectiveness, suggesting its potential as an adjuvant therapy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...